(1)
Khan, N.; Khan , A.; Umar, Z.; Muhammad, F.; Abbas , M.; Ahmed , A.; Zarmina , B.; Ullah , K. Prospective Evaluation of Atrial Fibrillation Risk in Type 2 Diabetes Comparing SGLT-2 Inhibitors and DPP-4 Inhibitors. IJBR 2025, 3 (3), 69-75. https://doi.org/10.70749/ijbr.v3i3.797.